Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura

Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura have?

Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura has 119 citations in the OpenAlex counts ScholarIQ stores.

When was Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura published?

Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura has 2020 year in the ScholarIQ index.

What is the open-access status of Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura?

Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura has gold oa status in the ScholarIQ index.

What is the DOI of Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura?

The DOI for Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura is on the source record.

What is the PMID of Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura?

The PMID for Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura is on the source record.

What is the OpenAlex record for Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura?

The OpenAlex for Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura is on the source record.